您好,欢迎访问北京市农林科学院 机构知识库!

Residue behavior and risk assessment of pyraclostrobin and tebuconazole in peppers under different growing conditions

文献类型: 外文期刊

作者: Zhao, Ercheng 1 ; Xie, Anqi 1 ; Wang, Dong 1 ; Du, Xiaoying 1 ; Liu, Bingjie 1 ; Chen, Li 1 ; He, Min 1 ; Yu, Pingzhong 1 ; Jing, Junjie 1 ;

作者机构: 1.Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing 100097, Peoples R China

关键词: Pyraclostrobin; Tebuconazole; Residue; Peppers; Risk assessment

期刊名称:ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH ( 影响因子:5.19; 五年影响因子:5.053 )

ISSN: 0944-1344

年卷期: 2022 年 29 卷 56 期

页码:

收录情况: SCI

摘要: This study evaluates the residue behavior and risks of pyraclostrobin and tebuconazole in peppers. An analytical method for the simultaneous determination of the concentration of these fungicides in peppers was developed using ultra-high performance liquid chromatography-triple quadrupole mass spectrometry. Pepper samples were extracted with acetonitrile and cleaned with primary secondary amine and graphitized carbon black. The average recoveries of pyraclostrobin and tebuconazole under three fortification levels were 86.7-101.4% and 81.7-104.4%, with relative standard deviations of 4.0-7.2% and 3.8-10.9%, respectively. The limit of quantification of both fungicides in peppers was 0.01 mg/kg. The terminal residue trial of 30% pyraclostrobin and tebuconazole suspension concentrate was investigated for samples cultivated in open fields and greenhouses. The results showed that the terminal residues of pyraclostrobin and tebuconazole in peppers were lower than the maximum residue limits established by GB 2763-2021 (0.5 mg/kg for pyraclostrobin and 2 mg/kg for tebuconazole). The results of a statistical t-test indicated that there was no significant difference between samples grown in open fields and greenhouses. According to the international estimate of short-term intake (IESTI) calculation model, provided by the Joint FAO/WHO Meeting on Pesticide Residues, the acute dietary exposure risk of both fungicides in peppers was acceptable for the general population, with an IESTI of 0-3% and 0-5% of the acute reference dose for pyraclostrobin and tebuconazole, respectively.

  • 相关文献
作者其他论文 更多>>